Literature DB >> 11567105

Heparin binding by the HIV-1 tat protein transduction domain.

S Hakansson1, A Jacobs, M Caffrey.   

Abstract

The protein transduction domain from the HIV-1 tat protein (termed PTD-tat) has been fused to the C-terminus of a model cargo protein, the IgG binding domain of streptococcal protein G. We demonstrate that PG-Ctat (PTD-tat fused to the C-terminus of protein G) binds to a heparin affinity column. PG-Ctat binds with relatively high affinity, as shown by its elution at 1.6 M NaCl. The heparin binding properties of PTD-tat are consistent with the idea that heparan sulfate, an analog of heparin found at the cell surface, plays a role in the translocation of PTD-tat fusions. We suggest that the heparin-binding properties of PTD-tat can be exploited for purification of PTD-tat fusions in the absence of affinity tags.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567105      PMCID: PMC2374215          DOI: 10.1110/ps.23401

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  9 in total

1.  In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA.

Authors:  S R Schwarze; S F Dowdy
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

2.  Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.

Authors:  M Tyagi; M Rusnati; M Presta; M Giacca
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 3.  Cell surface heparan sulfate proteoglycans.

Authors:  M Yanagishita; V C Hascall
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

4.  A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G.

Authors:  A M Gronenborn; D R Filpula; N Z Essig; A Achari; M Whitlow; P T Wingfield; G M Clore
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

5.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.

Authors:  H Nagahara; A M Vocero-Akbani; E L Snyder; A Ho; D G Latham; N A Lissy; M Becker-Hapak; S A Ezhevsky; S F Dowdy
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

6.  Design of an expression system for detecting folded protein domains and mapping macromolecular interactions by NMR.

Authors:  J R Huth; C A Bewley; B M Jackson; A G Hinnebusch; G M Clore; A M Gronenborn
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

7.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

8.  Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.

Authors:  M Rusnati; D Coltrini; P Oreste; G Zoppetti; A Albini; D Noonan; F d'Adda di Fagagna; M Giacca; M Presta
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

9.  Investigation of the backbone dynamics of the IgG-binding domain of streptococcal protein G by heteronuclear two-dimensional 1H-15N nuclear magnetic resonance spectroscopy.

Authors:  J J Barchi; B Grasberger; A M Gronenborn; G M Clore
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

  9 in total
  21 in total

1.  A novel human derived cell-penetrating peptide in drug delivery.

Authors:  Jian Zhao; Peng Gao; Wei Xiao; Li-Qiang Fan; Fu-Jun Wang; Su-Xia Li; Jian-Wen Liu
Journal:  Mol Biol Rep       Date:  2010-11-16       Impact factor: 2.316

Review 2.  Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins.

Authors:  Lucian Soane; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

3.  On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.

Authors:  Miguel Mano; Cristina Teodósio; Artur Paiva; Sérgio Simões; Maria C Pedroso de Lima
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 4.  Internalization of cationic peptides: the road less (or more?) traveled.

Authors:  S M Fuchs; R T Raines
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

Review 5.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

6.  Tat-MyoD fused proteins, together with C2c12 conditioned medium, are able to induce equine adult mesenchimal stem cells towards the myogenic fate.

Authors:  Marco Patruno; Chiara Gomiero; Roberta Sacchetto; Ohad Topel; Alessandro Negro; Tiziana Martinello
Journal:  Vet Res Commun       Date:  2017-06-06       Impact factor: 2.459

7.  A HA2-Fusion tag limits the endosomal release of its protein cargo despite causing endosomal lysis.

Authors:  Ya-Jung Lee; Gregory Johnson; Grantham C Peltier; Jean-Philippe Pellois
Journal:  Biochim Biophys Acta       Date:  2011-06-06

8.  Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.

Authors:  Daniel P Reay; Michele Yang; Jon F Watchko; Molly Daood; Terrence L O'Day; Khaleel K Rehman; Denis C Guttridge; Paul D Robbins; Paula R Clemens
Journal:  Neurobiol Dis       Date:  2011-05-23       Impact factor: 5.996

Review 9.  Emerging treatments for progressive myoclonus epilepsies.

Authors:  Antonella Riva; Alberto Guglielmo; Ganna Balagura; Francesca Marchese; Elisabetta Amadori; Michele Iacomino; Berge Arakel Minassian; Federico Zara; Pasquale Striano
Journal:  Expert Rev Neurother       Date:  2020-03-17       Impact factor: 4.618

10.  Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction.

Authors:  Jacob M Gump; Ronald K June; Steven F Dowdy
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.